Meropan (Fluoxetine)

Fluoxetine blocks the serotonin transporter on presynaptic neurons, preventing reuptake of serotonin into the nerve terminal. This raises extracellular serotonin levels, enhancing serotonergic signaling throughout the brain, which contributes to mood elevation and reduction of anxiety and compulsive behaviors.

The specific dose of fluoxetine is determined by the prescribing clinician based on the individual’s condition, severity, and response to therapy. Typical starting doses may vary, and adjustments are made according to therapeutic effect and tolerability under medical supervision.

Fluoxetine’s safety in pregnancy and lactation is not fully established; the pregnancy category is listed as unknown. Clinicians weigh potential benefits against risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To order Meropan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Meropan (fluoxetine) is an SSRI, a class known for a relatively favorable side‑effect profile compared with older tricyclic antidepressants and monoamine oxidase inhibitors. It has a long half‑life, which can simplify dosing and reduce withdrawal symptoms, but individual response varies and selection should be personalized by a clinician.

Meropan should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Meropan is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include serotonin syndrome, which can present with agitation, rapid heart rate, high blood pressure, and fever; emergent suicidal thoughts or behaviors, especially in young adults; severe allergic reactions; QT interval prolongation; and hyponatremia. Immediate medical attention is required if any of these occur.

Meropan should be avoided in patients currently taking monoamine oxidase inhibitors, those with known hypersensitivity to fluoxetine or any SSRI components, and individuals with a history of severe cardiac arrhythmias when combined with certain antipsychotics. Clinicians must also assess contraindications related to hepatic impairment and pregnancy.